The Role of Basiliximab Induction Therapy in Adult-to-Adult Living-Related Transplantation and Deceased Donor Liver Transplantation: A Comparative Retrospective Analysis of a Single-Center Series

Transplantation Proceedings

Volumn 40, Issue 6, 2008, Pages 1953-1955

  Vigano J ^a,b   Gruttadauria, S ^a   Mandala L ^a   Petridis, I ^a   Cintorino, D ^a   Li Petri, S ^a   Varotti, G ^a   Minervini, M ^a   Volpes, R ^a   Biondo, D ^a   Vizzini, G ^a   Marsh, W J ^c   Marcos, A ^c   Gridelli, B ^a  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C VIRUS; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADULT; ANTIBODIES, MONOCLONAL; CADAVER; DRUG THERAPY, COMBINATION; FAMILY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; PROBABILITY; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TACROLIMUS; TISSUE DONORS;

EID: 48049089644     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.062     Document Type: Article

References (9)

1. Marcos A. Right lobe living donor liver transplantation: a review. Liver Transpl 6 (2000) 3
2. Ringe B., Moritz M., Zeldin G., et al. What is the best immunosuppression in living donor liver transplantation. Transplant Proc 37 (2005) 2169
3. Moser M.A.J. Options for induction immunosuppression in liver transplant recipients. Drugs 62 (2002) 995
4. Kahan B.D., Rajagopalan P.R., and Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. Transplantation 67 (1999) 276
5. Gruttadauria S., Marsh J.W., Cintorino D., et al. Adult to adult living-related liver transplantation: report on an initial experience in Italy. Dig Liver Dis 39 (2007) 342
6. Ramirez C.B., and Marino I.R. The role of basiliximab induction therapy in organ transplantation. Expert Opin Biol Ther 7 (2007) 137
7. Marino I.R., Doria C., Scott V.L., et al. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. Transplantation 78 (2004) 886
8. Calmus Y., Scheele J.R., Gonzalez-Pinto I., et al. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptormonoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl 8 (2002) 123
9. Neuhaus P., Clavien P.A., Kittur D., et al., CHIC 304 International Liver Study Group. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl 8 (2002) 132